Linyan Xu

4PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 22, 2026
Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial.

|Feb 01, 2026
Sodium butyrate induces apoptosis enhanced by JAK2 inhibitor Fedratinib in NK/T-cell lymphoma cell.

Dongyun Tu, Tianyi Lu, Meng Zhang

|Oct 24, 2023
Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma.

Linyan Xu, Meng Zhang, Dongyun Tu

|Jun 27, 2022
l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.

Wei Sang, Dongyun Tu, Meng Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Dongyun Tu

1 joint publications

Xiangmin Wang

1 joint publications

Qing Zhang

1 joint publications

Dongmei Yan